Indianapolis-based Eli Lilly will sell its COVID-19 monoclonal antibody treatment to healthcare systems, hospitals and states this month, The Wall Street Journal reported Aug. 3.
Read the full post on Becker's Hospital Review - Healthcare News
Antibody drug to be sold commercially amid dwindling federal supply
